GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Research & Development

Inventage Lab (XKRX:389470) Research & Development : ₩9,412.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Inventage Lab's Research & Development for the three months ended in Mar. 2024 was ₩0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩9,412.9 Mil.

Inventage Lab Research & Development Historical Data

The historical data trend for Inventage Lab's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Research & Development Chart

Inventage Lab Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
1,858.58 4,254.06 8,795.55 10,957.55 12,204.91

Inventage Lab Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,791.96 4,586.00 3,276.82 1,550.13 -

Inventage Lab Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩9,412.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventage Lab  (XKRX:389470) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Inventage Lab Research & Development Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Research & Development
Comparable Companies
XKRX:003120 XKRX:061250 XKRX:006620 XKRX:330350 XKRX:054670 XKRX:000230 XKRX:063160 XKRX:067290 XKRX:002210 XKRX:183490 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403
Website
https://www.inventagelab.com
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines